Regulation of corneal repair by particle-mediated gene transfer of opioid growth factor receptor complementary DNA

Archives of Ophthalmology

Volumn 124, Issue 11, 2006, Pages 1620-1624

  Zagon, Ian S ^a   Sassani, Joseph W ^a   Malefyt, Kristin J ^a   McLaughlin, Patricia J ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; COMPLEMENTARY DNA; GROWTH FACTOR RECEPTOR; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA INJURY; DNA SYNTHESIS; EXPERIMENTAL RAT; FLUORESCENCE ANGIOGRAPHY; GENE GUN; GENE TRANSFER; NONHUMAN; NUCLEIC ACID PROBE; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; RAT; WOUND HEALING;

ANIMALS; BIOLISTICS; CORNEA; DNA; DNA, ANTISENSE; DNA, COMPLEMENTARY; EYE INJURIES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUOROPHOTOMETRY; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; MALE; PLASMIDS; RATS; RECEPTORS, OPIOID; WOUND HEALING; WOUNDS, NONPENETRATING;

EID: 33750997296     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.11.1620     Document Type: Article

References (20)

1. Starck T, Hersh PS, Kenyon KR. Corneal dysgenesis, dystrophies, and degenerations. In: Albert DM, Jakobiec FA, Azar DT, Gragoudas ES, eds. Principles and Practice of Ophthalmology. Vol 2. 2nd ed. Philadelphia, Pa: Saunders; 2000:2695-2755.
2. Smolin G, Thoft RA, eds. The Cornea. 3rd ed. Boston, Mass: Little Brown & Co; 1994.
3. Groos EB. Neurotrophic keratitis. In: Krachmer JH, ed. Cornea: Fundamentals of Corneal and External Diseases. St. Louis, Mo: Mosby; 1997:1339-1362.
4. Schultz RO, Van Horn DL, Peters MA, Klewin KM, Schutten WH. Diabetic keratopathy. Trans Am Ophthalmol Soc. 1981;79:180-189.
5. Zagon IS, Sassani JW, Verderame MF, McLaughlin PJ. Particle-mediated gene transfer of OGFr cDNA regulates cell proliferation of the corneal epithelium. Cornea. 2005;24:614-619.
6. Zagon IS, Sassani JW, McLaughlin PJ. Re-epithelialization of the rabbit cornea is regulated by opioid growth factor. Brain Res. 1998;803:61-68.
7. Zagon IS, Sassani JW, McLaughlin PJ. Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors. Brain Res. 1998;798:254-260.
8. Zagon IS, Sassani JW, McLaughlin PJ. Reepithelialization of the human cornea is regulated by endogenous opioids. Invest Ophthalmol Vis Sci. 2000;41:73-81.
9. Zagon IS, Jenkins JB, Sassani JW, et al. Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat. Diabetes. 2002;51:3055-3062.
10. 5]-enkephalin, in ocular surface epithelium. Brain Res. 1998;792:72-78.
11. 5] enkephalin, and the zeta (ζ) opioid receptor in vertebrate cornea. Brain Res. 1995;671:105-111.
12. Zagon IS, Sassani JW, McLaughlin PJ. Opioid growth factor modulates corneal outgrowth in tissue culture. Am J Physiol. 1995;268:R942-R950.
13. Zagon IS, Sassani JW, Kane ER, et al. Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor. Brain Res. 1997;759:92-102.
14. Zagon IS, Ruth TB, Leure-duPree AE, et al. Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea. Brain Res. 2003;967:37-47.
15. 5] enkephalin. Brain Res. 1999;849:147-154.
16. Zagon IS, Sassani JW, McLaughlin PJ. Cellular dynamics of corneal wound reepithelialization in the rat, I: fate of ocular surface epithelial cells synthesizing DNA prior to wounding. Brain Res. 1999;822:149-163.
17. Kirchmayer U, Davoli M, Verster A. Naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev. 2003;2:CD001333.
18. Rohsenow DJ. What place does naltrexone have in the treatment of alcoholism? CNS Drugs. 2004;18:547-560.
19. Klocek MS, Sassani JW, McLaughlin PJ, et al. Naltrexone as a novel treatment of diabetic keratopathy: efficacy studies [abstract]. Invest Ophthalmol Vis Sci. 2006;47:E2761.
20. Zagon IS, Sassani JW, Klocek MS, et al. Naltrexone as a novel treatment for diabetic keratopathy: toxicity studies [abstract]. Invest Ophthalmol Vis Sci. 2006;47:E2762.